Nobody at a frontier lab is working on your disease

Frontier labs walking into drug discovery looks like an extinction event for seed-stage biotech.

Alphabet ran the same experiment for twelve years across Calico, Verily and Isomorphic, and came up empty.

Capital, patience and a Nobel-winning model were never the scarce inputs. Proprietary data and a program someone sees through still are.